| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $74.9M | +5.0% |
| Cost of Revenue | $20.7M | +5.5% |
| Gross Profit | $54.2M | +4.8% |
| R&D Expense | $12.8M | +34.2% |
| SG&A Expense | $30.3M | +19.3% |
| Operating Income | -$34.6M | -13.1% |
| Interest Expense | $7.3M | +34.3% |
| Net Income | -$43.7M | -44.8% |
| EPS (Basic) | -$1.38 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.5M | -69.1% |
| Accounts Receivable | $23.4M | +48.0% |
| Inventory | $4.2M | -47.5% |
| Current Assets | $58.1M | -38.0% |
| Total Assets | $140.9M | +21.6% |
| Current Liabilities | $31.3M | +57.8% |
| Long-term Debt | $55.2M | -7.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.0M | +3.2% |
| Investing Cash Flow | -$2.4M | -82.5% |
| Financing Cash Flow | -$6.8M | -130.0% |
| -31.4% |
| EPS (Diluted) | -$1.38 | -31.4% |
| Total Liabilities |
| $109.1M |
| +33.6% |
| Stockholders' Equity | $27.7M | -19.0% |